Recruiting "clean" chronic insomnia participants: the unicorn of sleep research
- PMID: 35499132
- PMCID: PMC9340603
- DOI: 10.5664/jcsm.10088
Recruiting "clean" chronic insomnia participants: the unicorn of sleep research
Conflict of interest statement
All authors have seen and approved this manuscript. Work for this study was performed at Montana State University. This study was funded by the Merck Investigators Studies Program (MISP) (J.R.C). Additionally, the main study sponsor (Merck) has an FDA-approved drug for insomnia (Suvorexant) on the market in the USA and elsewhere. Clinical Trial Information: Information presented in the manuscript is part of an ongoing clinical trial. Title: Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia, URL:
Figures
Comment in
-
The dirty (not-so-little) secret about "clean" insomnia.J Clin Sleep Med. 2022 Dec 1;18(12):2877-2878. doi: 10.5664/jcsm.10276. J Clin Sleep Med. 2022. PMID: 36453604 Free PMC article. No abstract available.
References
-
- Bigalke JA, Carter JR . Sympathetic neural control in humans with anxiety-related disorders . Compr Physiol. 2021. ; 12 ( 1 ): 3085 – 3117 . - PubMed
-
- American Academy of Sleep Medicine . International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd ed . Westchester, IL: : American Academy of Sleep Medicine; ; 2005. .
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
